While genome-wide methylation profiling studies suggest RUNX3 methylation variance in IBD [13,14], mouse models of cytokine gene expression have shown T-bet-dependent induction of Runx3 in CD4+ T lymphocytes. This evidence concerns the gene RUNX3 and inflammatory bowel disease.